ASPSCR1, through its fusion with TFE3, plays a pivotal role in the development of alveolar soft part sarcoma by acting as an aberrant transcriptional transactivator, leading to deregulated transcription and oncogenesis (46). Here, TFE3 is linked to alveolar soft part sarcoma.